Malaysia’s CCM Duopharma Biotech Bhd has picked up a 5.8 per cent stake in Korean SCM Lifescience while auto parts maker MeGroup is looking to raise S$2.4 million ($1.7 million) via its IPO on the Catalist board.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
